Shares of Cipla were trading 2% above on 27 October after the company announced its quarterly earnings for the July-September. The Indian pharma major reported...
Cipla shares were trading in the red on 12 October after the USFDA (US Food and Drug Administration) inspected the companyβs American facility and issued...
Cipla shares fell as much as 2% during the trading session on 21 September after InvaGen Pharmaceuticals, its wholly-owned subsidiary, received 5 inspectional observations from...
Cipla’s shares are in the limelight today after the Konkan division of the Food and Drug Administration had ordered the suspension of the license issued...
Ciplaβs Pithampur Manufacturing Facility has received a current Good Manufacturing Practices (cGMP) inspection by the USFDA (the United States Food and Drug Administration) from 6...
Worldβs largest private equity fund, Blackstone, is set to submit a non-binding bid to acquire the entire 33.47% promoter stake in Cipla. The Hamied family,...
Cipla shares zoomed 9% in early morning trade after the business’s earnings for the April-June period exceeded the Street’s expectations. Numerous brokerages raised their price...
On April 12, Pharmaceutical major Cipla shares plunged 1.5% higher in early trade after a large deal, including the exchange of 12.56 lakh shares or...